MBS8(1V270)

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameMBS8(1V270)
Drug Alias NameMBS8(1V270)
ClassificationBiologics
Mechanisms of ActionToll like receptor 7 agonists
TargetsToll like receptor 7
Therapy Area/IndicationsUveal melanomaSkin MelanomaSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkSpain
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMonTa Biosciences ApS
China Registration ClassN/A

Develop Information

Active CompaniesMonTa Biosciences ApS
Inactive CompaniesN/A
Active IndicationsUveal melanomaSkin MelanomaSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A